Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Current Oncology

Topics

Physics

Cancer Oncology

Medicine

Internal Medicine

Surgery

Show all topics

DOI

10.3390/curroncol31120574

License

CC-BY